Cholelithiasis

01/01/2007 - "The clinical studies describe cholesterol supersaturation in bile and increased frequency of cholelithiasis as well. "
09/01/1999 - "The Syrian golden hamster is a frequently used model to study cholesterol and bile acid metabolism as well as cholesterol-induced cholelithiasis. "
11/01/1993 - "In the present study, we examined the effect of the following factors on a hamster model of cholesterol cholelithiasis: (i) the source of the golden Syrian hamsters (Sasco, Omaha, NE or Charles River, Wilmington, MA), (ii) the sex of the experimental animals and (iii) their age (4 wk vs. 8 wk of age). "
02/01/1987 - "The ground squirrel fulfills all criteria required to be regarded as an excellent animal model and is well suited for continued study into the role of the epithelial cell during cholesterol cholelithiasis."
05/01/1977 - "These data suggest that the baboon may be an inappropriate model for studies of the relationship of pregnancy to cholesterol cholelithiasis in humans. "

02/01/1993 - "[Computed X-ray tomography in predicting the efficacy of oral cholelithiasis with bile acids]."
03/01/1985 - "Studies on the effects of pH and bile acids in regard to its role in the pathogenesis of cholelithiasis."
01/01/2014 - "production and chemical compounds, synthesis of bile acids, their hepato-intestinal circulation with respect to etiology of cholelithiasis - its epidemiology and clinical aspects. "
01/01/2001 - "It was found that SCFA absolute and relative concentration in the feces of cholelithiasis patients is abnormal indicating disturbance of microbiocenosis as shown by changes in functional activity of some anaerobes of the intestinal microflora participating in enterohepatic circulation of bile acids. "
04/01/1995 - "ESWL with bile salts as treatment for symptomatic cholelithiasis is not recommended for routine use."

02/01/1994 - "Therefore, intermittent therapy may allow clearance of stagnated bile and hence decrease the incidence of cholelithiasis in acromegalic patients receiving long term octreotide therapy."
09/01/1993 - "Therefore, discontinuation of octreotide therapy may allow for the clearance of stagnated bile and hence decrease the incidence of cholelithiasis in acromegalic patients receiving long-term therapy."
11/01/1995 - "No patient developed symptomatic cholelithiasis while receiving octreotide therapy. "
03/01/1994 - "Asymptomatic stones were recorded in 13/49 patients (26.5%) prior to octreotide treatment (the prevalence of cholelithiasis in the Italian population is 9.5% in men and 18.9% in women). "
02/01/1994 - "We sought to examine the feasibility of intermittent dosing of octreotide in acromegalics to avoid the well-documented side effect of cholelithiasis. "

04/01/2008 - "Currently, the bile acid UDCA (Ursodeoxycholic acid) is used for oral dissolution treatment and for the prevention of cholelithiasis in selected cases. "
03/01/2008 - "Resolution of the infant's cholelithiasis occurred following treatment with ursodeoxycholic acid."
01/01/2007 - "[Effect of ursodeoxycholic acid on the characteristics of lipid metabolism in cholelithiasis and gall-bladder cholesterosis]."
05/01/1993 - "The use of ursodeoxycholic acid (UDCA) was found useful in reducing the incidence of cholelithiasis (p < 0.05) without provoking any other alteration in hepatic function. "
04/01/1993 - "Ursodeoxycholic acid (UDCA) is a hydrophilic biliary acid that has been used in the medical therapy of cholelithiasis. "

07/01/1997 - "The purpose of this study was to evaluate the efficacy of diclofenac, a potent NSAID, in the the immediate symptomatic relief of biliary colic and the prevention of cholelithiasis-related complications. "
07/01/1997 - "In patients with cholelithiasis who present with biliary colic, a single 75-mg intramuscular dose of diclofenac can provide satisfactory pain relief and decrease substantially the rate of progression to acute cholecystitis."
07/01/2004 - "The objective of the present study is to compare the efficacy of intramuscular diclofenac with intramuscular hyoscine in the treatment of pain of acute biliary colic, and to study their role in the natural history of biliary colic and in the prevention of cholelithiasis-related complications. "

06/01/1998 - "Seventy-eight patients with an abnormal GEF (< 35%) on cholecystokinin hepatobiliary scan without cholelithiasis were studied retrospectively. "
04/01/1997 - "Different pathways mediate cholecystokinin actions in cholelithiasis."
09/01/1987 - "Duodenal fluid was collected from patients with suspected cholelithiasis (n = 10) before and after pancreozymin-cholecystokinin injection. "
03/01/1983 - "For an equivalent dose of cholecystokinin, the gallbladder in cholelithiasis is less responsive than in normal subjects."
11/01/1980 - "After a 5-min time lag, gallbladder empyting commenced in response to the cholecystokinin, ejecting half its contents in 12 min, but still having a residual 25% after 30 min. Gallbladder evacuation was definitely slower in 6 patients with cholelithiasis, although filling appeared normal. "

01/01/1991 - "The prevention of cholelithiasis with infused sodium chenodeoxycholate in the prairie dog (Cynomys ludovicianus)."
05/01/1990 - "Conservative management with chenodeoxycholic acid completely resolved cholelithiasis following four months of treatment. "
01/01/1984 - "[Long-term use of chenodeoxycholic acid in patients with cholelithiasis]."
06/01/1983 - "Although better chemotherapeutic agents are needed, chenodeoxycholic acid is a reasonable choice for patients with non-calcified cholelithiasis in a functioning gallbladder if the patient is a heightened surgical risk. "
06/01/1983 - "Drug and treatment efficacy of chenodeoxycholic acid in 97 patients with cholelithiasis and increased surgical risk."

01/01/2003 - "The latest findings on efficacy of litholytic therapy in BS and data on possible use of nonsteroid anti-inflammatory drugs as inhibitors of mucin production to prevent recurrent cholelithiasis are presented."
11/01/2002 - "Characterization of the pathophysiologic roles of Lith3 and the new biliary mucin gene Glycam1 might provide insights into primary defects of human cholelithiasis and lead to new therapeutic strategies for prestone intervention."
04/30/1992 - "[Morphofunctional analysis of mucins and endocrine cells in the gallbladder epithelium in uncomplicated cholelithiasis]."
04/01/1991 - "Mucin-producing cells and endocrine cells of gallbladder epithelium in patients with uncomplicated cholelithiasis."
09/01/1984 - "In nearly all animal models of cholelithiasis, mucin hypersecretion is prominent. "

10/01/2014 - "Cholelithiasis co-existed in 15 cases (19.2 %). "
03/01/2014 - "The aim of this study was to compare the efficacy of a wait-and-see policy versus cholecystectomy after ES for CBD stones in high-risk patients with co-existing cholelithiasis. "
04/01/1996 - "[The effect of co-existing diseases with cholelithiasis on the course and results of laparoscopic cholecystectomy]."
09/01/2009 - "The study group consisted of 40 patients, operated on due to cholelithiasis using standard-pressure (n = 20) and low-pressure (n = 20) CO(2) pneumoperitoneum. "
01/01/2013 - "Cholecystogastric fistula is a rare, life-threatening complication of cholelithiasis that presents a difficult challenge to the surgeon when it occurs in elderly and co-morbid patients. "

04/01/1996 - "Experimental cholelithiasis is associated with elevated biliary calcium concentration and altered gallbladder absorption. "
09/01/1984 - "All animal models of calcium cholelithiasis probably share a common pathogenesis--an increased concentration of a calcium-sensitive anion. "
09/01/1984 - "Animal models of calcium cholelithiasis."
01/01/1990 - "[The calcium content in the bile of patients with cholelithiasis, chronic hepatitis, liver cirrhosis and in healthy subjects]."
09/01/1999 - "Specific risk factors for outcome were assessed including low cardiac output, intra-aortic balloon pump usage, exogenous calcium repletion, immunosuppression, cytomegalovirus infection, cholelithiasis, prior pancreatitis, and Acute Physiology and Chronic Health Evaluation (APACHE) II scores. "

01/01/1995 - "This study reveals that laparoscopic cholecystectomy is the most effective treatment of the large majority of patients with symptomatic cholelithiasis. "
07/01/2007 - "Laparoscopic cholecystectomy was highly effective in cases of symptomatic cholelithiasis. "
04/01/2001 - "Both open and laparoscopic cholecystectomy are highly safe and effective procedures for patients with symptomatic cholelithiasis. "
04/01/2015 - "Although laparoscopic cholecystectomy has become a gold standard in treatment of symptomatic cholelithiasis, it is associated with higher risk of intraoperative lesions and primarily lesions of biliary ducts. "
09/01/2014 - "Diagnostic and therapeutic standardization is still missing, especially since laparoscopic cholecystectomy has become the gold standard approach for symptomatic cholelithiasis. "

08/01/1993 - "These data indicate that open cholecystectomy currently is a very safe, effective treatment for cholelithiasis and is being performed with near zero mortality. "
01/01/1990 - "We concluded that cholecystectomy is a definitive treatment for symptomatic cholelithiasis with minimal risk to the patient and a high degree of relief from symptoms. "
09/01/2013 - "Laparoscopy cholecystectomy for the surgical treatment of cholelithiasis has been considered the gold standard. "
01/01/1996 - "Cholecystectomy has been considered as the gold standard in the treatment of symptomatic or complicated cholelithiasis. "
05/16/1995 - "The gold standard in treatment of cholelithiasis is and remains cholecystectomy. "

01/01/2011 - "Percutaneous treatment of cholelithiasis by monotherapy was effective in 89.8% of the patients, in 10% of the patients distant lithotripsy was performed for residual stones. "
09/01/1989 - "This study lends credence to the findings of previous studies and demonstrates that lithotripsy combined with bile acid therapy is a useful therapy for cholelithiasis."
07/01/1993 - "[Extracorporeal shockwave lithotripsy in cholelithiasis]."
06/15/1992 - "[Results of extracorporeal lithotripsy in the treatment of cholelithiasis]."
04/01/1992 - "19, 1989 and Nov. 23, 1990, 170 patients with symptomatic cholelithiasis were evaluated for possible treatment by extracorporeal shockwave lithotripsy (ESWL). "

06/01/1990 - "The two patients with angiocholitis improved significantly; in both cases it was shown that the cause was cholelithiasis: later on, they were treated by different methods (endoscopic sphincterotomy in one case and surgery in the third case). "
08/01/1993 - "The introduction of endoscopic sphincterotomy has considerably changed the treatment of cholelithiasis. "
01/01/1989 - "Follow-up of 54 of the patients, who had associated cholelithiasis at the time of endoscopic sphincterotomy, showed that 14 died of causes unrelated to the biliary tract. "
04/01/1984 - "[Retained cholelithiasis--a risk factor after endoscopic papillotomy?]."
01/01/1982 - "[Endoscopic papillotomy in the treatment of cholelithiasis]."

07/01/1999 - "This study set out to evaluate the frequency in which symptomatic cholelithiasis subsequently develops in children treated by splenectomy alone. "
03/01/2014 - "The need for splenectomy in patients with mild HS and symptomatic cholelithiasis should be assessed on a case by case basis. "
09/01/2011 - "Cholelithiasis was found in 25.5% and was correlated with age and history of splenectomy. "
01/01/2012 - "The events of interest were need for blood transfusion, cholelithiasis, splenic sequestration, aplastic crisis, and splenectomy. "
07/01/1999 - "None of the patients in this series subsequently have undergone cholecystectomy, nor have any had either clinical or subclinical evidence of cholelithiasis since splenectomy. "